M2454035
Eslicarbazepine , 98% , 104746-04-5
Pack Size | Price | Stock | Quantity |
5mg | RMB547.20 | In Stock |
|
10mg | RMB912.00 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 188-190°C |
Boiling point: | 431.3±55.0 °C(Predicted) |
Density | 1.336 |
storage temp. | -20°C Freezer |
solubility | Chloroform (Slightly, Heated), Methanol (Slightly), Pyridine (Slightly) |
form | Solid |
pka | 13.75±0.20(Predicted) |
color | White to Pale Yellow |
InChI | InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1 |
InChIKey | BMPDWHIDQYTSHX-AWEZNQCLSA-N |
SMILES | N1(C(N)=O)C2=CC=CC=C2[C@@H](O)CC2=CC=CC=C12 |
Description and Uses
Eslicarbazepine (also known as (S)-10-Monohydroxy-10,11-dihydro Carbamazepine) is a voltage-gated sodium channel (Nav) inhibitor and the active metabolite of the prodrug eslicarbazepine acetate. It enhances the slow activation of voltage-gated sodium channels, thereby reducing channel availability. Eslicarbazepine is an oral anticonvulsant used as an adjunctive treatment for partial-onset seizures.
(S)-10-Monohydroxy-10,11-dihydro Carbamazepine is the metabolite of Eslicarbazepine acetate, (BIA 2-093), (E659000) a novel central nervous system drug.
Safety
Symbol(GHS) | ![]() GHS07 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 |